ABIE:XETRA:XETRA-AXA IM ACT Biodiversity Equity UCITS ETF EUR(H) Acc (EUR)

ETF | Others |

Last Closing

USD 12.62

Change

0.00 (0.00)%

Market Cap

N/A

Volume

58.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

ETFs Containing ABIE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.28% 46% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.28% 44% F 48% F
Trailing 12 Months  
Capital Gain 8.23% 48% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.23% 47% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.20% 54% F 54% F
Dividend Return 7.20% 52% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.50% 68% D+ 75% C
Risk Adjusted Return 84.66% 77% C+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike